» Articles » PMID: 169893

Characterization of Novikoff Hepatoma MRNA Methylation and Heterogeneity in the Methylated 5' Terminus

Overview
Journal Biochemistry
Specialty Biochemistry
Date 1975 Oct 7
PMID 169893
Citations 87
Authors
Affiliations
Soon will be listed here.
Abstract

KOH digestion of methyl-labeled poly(A)+ mRNA purified by (dT)-cellulose chromatography produced mononucleotide and multiple peaks of a large oligonucleotide (-6 to -8 charge) when separated on the basis of charge by Pellionex-WAX high-speed liquid chromatography in 7 M urea. Heat denaturation of the RNA before application to (dT)-cellulose was required to release contaminants (mostly 18S rRNA) that persisted even after repeated binding to (dT)-cellulose at room temperature. Analysis of the purified poly(A)+ mRNA by enzyme digestion, acid hydrolysis, and a variety of chromatographic techniques has shown that the monucleotide (53%) is due entirely to N6-methyladenosine. The large oligonucleotides (47%) were found to contain 7-methylguanosine and the 2'-0-methyl derivatives of all four nucleosides. No radioactivity was found associated with the poly(A) segment. Periodate oxidation of the mRNA followed by beta elimination released only labeled 7-methylguanine consistent with a blocked 5' terminus containing an unusual 5'-5' bond. Alkaline phosphatase treatment of intact mRNA had no effect on the migration of the KOH produced oligonucleotides on Pellionex-WAX. When RNA from which 7-methylguanine was removed by beta elimination was used for the phosphatase treatment, distinct dinucleotides (NmpNp) and trinucleotides (NmpNmpNp) occurred after KOH hydrolysis and Pellionex-WAX chromatography. Thus Novikoff hepatoma poly(A)+ mRNA molecules can contain either one or two 2'-0-methylnucleotides linked by a 5'-5' bond to a terminal 7-methylguanosine and the 2'-0-methylation can occur with any of the four nucleotides. The 5' terminus may be represented by m7G5'ppp5' (Nmp)lor2Np, a general structure proposed earlier as a possible 5' terminus for all eucaryotic mRNA molecules (Rottman, F., Shatkin, A., and Perry, R. (1974), Cell 3, 197). The composition analyses indicate that there are 3.0 N6-methyladenosine residues, 1.0 7-methylguanosine residue, and 1.7 2'-0-methylnucleoside residues per average mRNA molecule.

Citing Articles

Small Nucleolar RNAs and the Brain: Growing Evidence Supporting Their Role in Psychiatric Disorders.

Salles J, Lin R, Turecki G Biol Psychiatry Glob Open Sci. 2025; 5(2):100415.

PMID: 39867567 PMC: 11758842. DOI: 10.1016/j.bpsgos.2024.100415.


The landscape of epigenetic regulation and therapeutic application of N-methyladenosine modifications in non-coding RNAs.

Xu G, Zhao X, Li G, Gokulnath P, Wang L, Xiao J Genes Dis. 2024; 11(5):101045.

PMID: 38988321 PMC: 11233902. DOI: 10.1016/j.gendis.2023.06.015.


RNA m6A dynamic modification mediated by nucleus-localized FTO is involved in follicular reserve.

Zhang J, Wang R, Klinger F, Cheng S, Shen W, Sun X Zool Res. 2024; 45(2):415-428.

PMID: 38485509 PMC: 11017081. DOI: 10.24272/j.issn.2095-8137.2023.236.


RNA Modifications in Hematologic Malignancies.

Li Y, Tian W, Zhang H Cancer Treat Res. 2023; 190:181-207.

PMID: 38113002 DOI: 10.1007/978-3-031-45654-1_6.


MA Demethylase Inhibits Osteogenesis of Dental Follicle Stem Cells via Regulating miR-7974/FKBP15 Pathway.

Zheng L, Li Z, Wang B, Sun R, Sun Y, Ren J Int J Mol Sci. 2023; 24(22).

PMID: 38003310 PMC: 10671807. DOI: 10.3390/ijms242216121.